Back

Diagnostic utility of three clinical scoring systems for transthyretin amyloid cardiomyopathy in elderly Asian patients with heart failure with preserved ejection fraction

30 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: New insights into cardiac amyloidosis Infiltrative Myocardial Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Min-Jhih Chen

National Taiwan University, Taipei (Taiwan)

7 More presentations in this session

Presentation thumbnail
Decoding peripartum cardiomyopathy through multi-omics: circulating and cellular signatures from the Italian multicenter registry
Doctor M. Carotenuto (Naples, IT)
Abstract
Presentation thumbnail
Premature hypertensive heart disease in working-age adults: global burden, inequalities and missed prevention opportunities (GBD 2021)
Doctor X. Dong (Beijing, CN)
Abstract
Presentation thumbnail
Vascular dysfunction is associated with symptom severity and quality of life in wild-type transthyretin amyloid cardiomyopathy
Mr N. Ogasawara (Akita, JP)
Abstract
Presentation thumbnail
Improvement of health status with acoramidis in patients with wild-type and variant transthyretin amyloid cardiomyopathy: KCCQ domains analysis from the ATTRibute-CM study
Doctor N. Sarswat (Chicago, US)
Abstract
Presentation thumbnail
Acoramidis improves health-related quality of life in wild-type and variant transthyretin amyloid cardiomyopathy: An EQ-5D-5L subgroup analysis from ATTRibute-CM
Doctor E. Joyce (Dublin, IE)
Abstract

Access the full session

Session thumbnail
New insights into cardiac amyloidosis

The Event

Event poster

ESC Congress 2026

30 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Validation of a clinical score for transthyretin amyloid cardiomiopathy in a mediterranean cohort of patients at risk
21 May 2023
thumbnail
Congress Presentation
Prognostic utility of atrial cardiomyopathy, HFA-PEFF, and H2FPEF scores in patients with sick sinus syndrome
12 April 2026
thumbnail
Congress Presentation
Patients with transthyretin amyloid cardiomyopathy may have preserved, mildly reduced, or reduced ejection fraction
27 August 2021
thumbnail
Congress Presentation
Hypertensive heart disease vs. Transthyretin cardiac amyloidosis: what are the differential features in real life?
1 July 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources